Abstract
We have analyzed the role of the Slit family of repellent axon guidance molecules in the patterning of the axonal projections of retinal ganglion cells (RGCs) within the embryonic rat diencephalon and whether the slits can account for a repellent activity for retinal axons released by hypothalamus and epithalamus. At the time RGC axons extend over the diencephalon, slit1 andslit2 are expressed in hypothalamus and epithalamus but not in the lateral part of dorsal thalamus, a retinal target.slit3 expression is low or undetectable. The Slit receptors robo2, and to a limited extentrobo1, are expressed in the RGC layer, as areslit1 and slit2. In collagen gels, axon outgrowth from rat retinal explants is biased away fromslit2-transfected 293T cells, and the number and length of axons are decreased on the explant side facing the cells. In addition, in the presence of Slit2, overall axon outgrowth is decreased, and bundles of retinal axons are more tightly fasciculated. This action of Slit2 as a growth inhibitor of retinal axons and the expression patterns of slit1 and slit2correlate with the fasciculation and innervation patterns of RGC axons within the diencephalon and implicate the Slits as components of the axon repellent activity associated with the hypothalamus and epithalamus. Our findings suggest that in vivo the Slits control RGC axon pathfinding and targeting within the diencephalon by regulating their fasciculation, preventing them or their branches from invading nontarget tissues, and steering them toward their most distal target, the superior colliculus.
- axon guidance
- axon fasciculation
- axon repellents
- chemorepellents
- robo1
- robo2
- hypothalamus
- retinal ganglion cells
Visual information is relayed from the eye to the brain via the axons of retinal ganglion cells (RGCs). RGC axons enter the brain at the ventral aspect of the hypothalamus. In rodents, essentially all RGCs project to their midbrain target, the superior colliculus (SC) (Linden and Perry, 1983). En route to the SC, RGC axons grow dorsally over the lateral surface of the diencephalon. A small fraction of RGC axons invade the ventral hypothalamus to form the retinohypothalamic projection (Johnson et al., 1988; Levine et al., 1991, 1994). In contrast, approximately one-third of RGC axons later extend branches into their targets in dorsal thalamus (e.g., the dorsal lateral geniculate nucleus) (Bhide and Frost, 1991).
The first RGC axons reach the ventral hypothalamus in rats on embryonic day 14 (E14), grow over the diencephalon, and reach the SC on E16 (Lund and Bunt, 1976; Bunt et al., 1983; Marcus and Mason, 1995). Later arriving RGC axons continue to grow over the diencephalon for several more days (Tuttle et al., 1998). RGC axons extend over the hypothalamus in a tight fascicle, defasciculate and spread over the surface of their dorsal thalamic targets, and then refasciculate into a tight bundle as they approach epithalamus and turn caudally toward the SC (Fig.1A) (Tuttle et al., 1998). This pattern of RGC axon growth over the diencephalon correlates within vitro observations that retinal axons can extend over an inhibitory substrate but in a highly fasciculated manner (Bray et al., 1980). Defasciculation of RGC axons over dorsal thalamus likely facilitates their branching and target innervation (Daston et al., 1996). Consistent with these axonal behaviors, we previously showed that in vitro the hypothalamus and epithalamus release soluble activities that repel rat and mouse retinal axons, whereas dorsal thalamus releases an activity that promotes their growth (Tuttle et al., 1998) (Fig. 1B). The molecular identities of these activities are unknown; however, members of the Slit family of secreted proteins are candidates for the repellent activity.
In Drosophila, the transmembrane receptor Roundabout (Robo) is expressed on axons, plays a role in preventing ipsilaterally projecting axons from crossing the midline and commissural axons that have crossed the midline from recrossing (Seeger et al., 1993; Kidd et al., 1998; Zallen et al., 1998). Mutant analysis suggests that Robo is a receptor for a midline repellent activity, subsequently shown to be Slit. In mammals, three slit genes, slit1,slit2, and slit3, and two Slit receptors,robo1 and robo2, have been identified (Itoh et al., 1998; Nakayama et al., 1998; Brose et al., 1999; Li et al., 1999). Slit2 has been shown to be a chemorepellent for olfactory bulb, hippocampal (Nguyen Ba-Charvet et al., 1999), and spinal motor axons (Brose et al., 1999). The objective of the present study was to evaluate the role of the Robos and Slits in the patterning of RGC projections within the embryonic rat diencephalon and whether the slits can account for the hypothalamic and epithalamic repellent activities.
MATERIALS AND METHODS
Animals
Sprague Dawley rats from E13 to E17 were obtained from timed-pregnant females (Harlan Sprague Dawley, Indianapolis, IN). Embryos were staged according to Butler and Juurlink (1987). The day of insemination was designated as E0.
In situ hybridization. Timed-pregnant rats (E13–E17) were anesthetized with sodium pentobarbital and cesarean-sectioned to expose the embryos. Embryos were decapitated, and the heads were fixed by immersion in 4% paraformaldehyde (Pfa). After cryoprotection (30% sucrose), the heads were coronally sectioned at 20 μm on a cryostat. The sections were fixed for 20 min in 4% Pfa, rinsed twice in PBS, and then delipidated in 2× standard SSC at 65° C for 30 min. After two rinses in water and PBS, the slides were acetylated for 10 min in 0.25% acetic anhydride in 0.1 methanolamine and then rinsed in PBS and alcohol-dehydrated. After drying, the sections were incubated overnight in a humidified chamber with 90 ml of hybridization buffer per slide (hybridization buffer is 50% formamide, 10% dextran sulfate, 1× Denhardt's solution, 0.3m NaCl, 10 mm Tris, pH 7.5, 10 mm sodium phosphate, pH 6.8, and 5 mm EDTA). Antisense RNA probes were added to a concentration of between 20,000 and 50,000 cpm/μl hybridization buffer. After hybridization, the sections were washed 30 min at 55°C in 5× SSC with 20 mm β-mercaptoethanol (β-me), 30 min in 1× SSC (with 20 mm β-me) at 65°C, 45 min at 65°C in 1× SSC, 50% formamide, and 20 mm β-me, and 2 hr at 37°C in 0.5× SSC, 50% formamide, and 20 mm β-me. They were then treated with RNase A (20 μg/ml) for 30 min at 37°C, washed three times for 15 min in 1× SSC at 60°C and 5 min in 0.2× SSC at room temperature. Finally, sections were dehydrated, dried, and dipped in Kodak (Eastman Kodak, Rochester, NY) NT-B2 emulsion. After 5–8 d, the slides were developed, stained with DAPI (Sigma, St. Louis, MO), and mounted in Permount. Probes were labeled with [35S]UTP by in vitrotranscription with T7 RNA polymerase from fragments of Slit1, Slit2, Slit3, Robo1, or Robo2 subcloned into PBS S/K (Stratagene, La Jolla, CA).
Preparation of explants
Timed-pregnant rats (E15) were anesthetized with sodium pentobarbital and cesarean-sectioned to expose the embryos. Embryos were decapitated, the eyes were removed, and retinas were dissected from surrounding tissues and cut into eight radially symmetric pieces without regard to the retinal axes. Explants were then cocultured overnight in DMEM–F12 with 2 mm glutamine, 0.1% penicillin–streptomycin, 20 mm HEPES, 0.6%d-glucose, and 10% rat serum (growth medium), supplemented with 10 μm cytosine arabinoside (AraC). Retinal axon growth is greater and more radially symmetric, and non-neuronal cell migration from the explants is reduced in cultures exposed briefly to AraC. At the concentrations and exposure times used here, AraC does not appear to have detrimental effects on neurons (Martin et al., 1990). The following day, explants were rinsed in DMEM–F12 and plated in growth medium without AraC as described below.
Preparation of aggregates ofslit2-transfected cells
293T cells were transfected with slit2-myc cDNA using SuperFect Transfection Reagent (Qiagen, Hilden, Germany). The expression vector was constructed by inserting a sequence encoding human Slit2 into the expression vector pSecTagB. pSecTagB without insert was used for mock transfections. Several days before transfection, confluent 60 mm plates were split 1:10. Subconfluent cells were then transfected as follows: 4 μg of DNA was diluted into DMEM to a final volume of 150 μl, and then 20 μl of SuperFect Transfection Reagent was added to the DNA solution. The samples were incubated for 5–10 min before adding 1 ml of DMEM with 0.1% penicillin–streptomycin and 10% FBS (cell growth medium). Cell growth medium was removed from the cells and replaced with the transfection solution. Two to 3 hr later, the transfection solution was removed, the cells were rinsed three times with PBS, and then 5 ml of cell growth medium was added to the dishes. After 24 hr, cells were harvested, centrifuged to a pellet, and resuspended in 100–300 μl of cell growth medium (see below). Agar blocks containing cells were then prepared as follows: 2% low melting point agar in DMEM–F12 was added to a 35 mm dish and allowed to gel. A 1 cm square was cut out and removed, and the dish was placed on a warming block. Thirty-five microliters of cells and 35 μl of molten 2% agar in DMEM–F12 was added to this cavity, mixed, and allowed to gel. Small cubes were then cut from the agar and placed in cell growth medium and cultured overnight. Cell blocks were then rinsed in L15–glucose and cut into smaller pieces (∼300–400 μm cubes) before plating.
Preparation of collagen gel cocultures
Collagen was prepared from adult rat tails. Cocultures were set up as follows: 900 μl of collagen solution was mixed with 100 μl of 10× MEM and 13–20 μl of a 1 m solution of sodium bicarbonate and placed on ice. Twenty-five microliters of collagen was pipetted onto the bottom of four-well dishes (Nunc, Naperville, IL) and allowed to gel. Retinal explants were then placed onto this base with a Pasteur pipette, excess L15-glucose was removed, and 75 μl of collagen was added on top. With forceps, retinal explants andslit2-myc- or vector (mock)- transfected 293T cell aggregates were positioned ∼150–300 μm apart. The collagen was then allowed to gel before adding 500 μl of DMEM–F12 containing 0.1% penicillin–streptomycin, 0.6% d-glucose, 2 mm glutamine, and 5% rat serum. Explants were cultured in a humidified 37°C, CO2incubator for 1–1.5 d.
Immunocytochemistry
Collagen gel cocultures were fixed for at least 1 d in 4% paraformaldehyde plus 1% glutaraldehyde at 4°C, rinsed numerous times in 0.1 m phosphate buffer, and then blocked for 2–4 hr in 10% lamb serum in PBS with 0.1% Triton X-100 (blocking buffer). Cocultures were then incubated 3–4 d at 4°C in mouse monoclonal anti-β tubulin antibody (Amersham Pharmacia Biotech, Arlington Heights, IL), diluted 1:500 in blocking buffer, rinsed numerous times in PBS, and incubated in Cy3-conjugated anti-mouse secondary antibody (Amersham Pharmacia Biotech), diluted 1:1000 in blocking buffer for 2 d. Cultures were then rinsed in PBS and stored at 4°C.
Analysis of axon outgrowth in collagen gel cocultures
After fixation, retina 293T cell cocultures were labeled with an anti-β tubulin monoclonal antibody (see above) and photographed using a 4× or 6.3× lens on a Nikon (Tokyo, Japan) Microphot fluorescence microscope. The micrographs were then scanned into Adobe Photoshop (Adobe Systems, San Jose, CA). Quantitation was done on the scanned images. All data were analyzed using Student's t test.
Number and length of axon bundles. On each image, a line was drawn through the center of the retinal explant, dividing it in two sectors, one facing toward and one away from the 293T cells (see Fig.6). Axon bundles were counted in both sectors, and their lengths were measured.
Directional effects. To determine whether retinal axons turn in response to Slit2, the axons angle of deviation away from the 293T cells was measured in the half of the explant facing toward the 293T cells (see Fig. 7A) as follows. A base line, perpendicular to the one dividing the explant in two sectors and to the surface of the 293T cells, was drawn. Another line, the expected direction of growth (Gx), was drawn through the center of the explant and the base of the axon bundle. A third line, representing the actual direction of growth (Ga) was then drawn through the base and the tip of the axon bundle. The absolute value of the angle between the baseline and Ga (AGa) was then subtracted from the absolute value of the angle between the baseline and Gx(AGx). The difference is negative when the axon bundle extends away from the 293T cells and positive when it grows toward them.
Fasciculation. Scanned images were transferred into Scion (Frederick, MD) Image (beta 3b). The optical density was measured as average pixel values (0–256) in a circular area centered at a position that corresponded to 75% of the length of the bundle from the explant. The diameter of the circle was adjusted to fit the width of the fascicle. All fascicles in the focal plane were measured, regardless of whether they projected toward or away from the explant. The background value of the image was measured as the average of several areas in the collagen gel at similar distances from the explant but devoid of axon bundles. The bundle values minus the mean background value were averaged for each coculture, and the average per coculture was calculated.
RESULTS
Expression of Slits in diencephalon
To determine whether the Slits may be involved in the controlling the pathfinding and innervation patterns of RGC axons within the diencephalon, we examined the expression patterns of the mammalian slit homologs slit1, slit2, and slit3, relative to the developing RGC axonal pathway. In situhybridizations were performed on coronal sections of E15 and E17 rat brains, ages when RGC axons grow over the diencephalon and a repellent activity for retinal axons is released by the hypothalamus and epithalamus (Tuttle et al., 1998).
At E15, slit1 is strongly expressed in the ventromedial part of ventral thalamus and throughout much of the hypothalamus, with particularly high levels in the dorsal two-thirds (Fig.2A). Slit2is highly expressed in medial ventral thalamus, as well as in discrete areas within the dorsal and ventral regions of hypothalamus (Fig.2C). In addition, slit1 is expressed weakly (Fig.2A) and slit2 is expressed strongly (Fig.2C) in epithalamus and just lateral to the dorsal thalamic ventricular zone. Neither slit1 (Fig. 2A) nor slit2 (Fig. 2B) are expressed in the lateral aspect of dorsal thalamus, a target of RGC axons.
At E17, both slit1 (Fig. 2B) andslit2 (Fig. 2D) continue to be highly expressed within the hypothalamus, with slit2 expression highest in the ventral half. At this age, a small wedge ofslit1 expression is present in the lateral aspect of dorsal thalamus (Fig. 2B). In addition, slit1 is expressed strongly in epithalamus and in a thin band at the midline of dorsal thalamus; slit2 expression is high in the epithalamic and dorsal thalamic ventricular zones. In contrast, at both E15 (Fig.2E) and E17 (Fig. 2F),slit3 expression in the diencephalon is very low (e.g., ventral hypothalamus and dorsal thalamus, except its lateral aspect) or nondetectable relative to slit1 and slit2.
These expression patterns of the Slits correlate with the fasciculation and innervation patterns of RGC axons within the diencephalon (for description, see Fig. 1). In summary, at the levels of the diencephalon over which the optic tract courses, we find that the combined expression of the Slits is high in the hypothalamus (high fasciculation, restricted sparse innervation), declines to lower levels in the lateral part of ventral thalamus (tract begins to defasciculate, restricted modest innervation), declines further to nondetectable levels throughout most of the lateral part of dorsal thalamus (tract is defasciculated, heavy innervation), and then increases to high levels in the epithalamus (high fasciculation and tract turns caudally, no innervation). These findings are consistent with a role for Slit1 and/or Slit2 as diencephalic repellents for RGC axons.
Expression of Slit receptors in retina
If slit1 and slit2 act as repellents for RGC axons, we would expect that robo1 and/or robo2, receptors for the Slits (Brose et al., 1999; Yuan et al., 1999), would be expressed by RGCs. To test this possibility, in situhybridizations were performed on sections through E13, E15, and E17 rat retinas, ages that cover the majority of the period of RGC axon growth.
At all ages examined, robo1 is expressed most strongly in the retinal marginal zone (Fig.3A–C). In addition, beginning at E15, scattered cells in the RGC layer in central retina are well labeled (Fig. 3B,G). By E17,robo1 expression is present at low levels throughout the retina, with punctate dense labeling in the forming RGC layer, indicative of scattered highly expressing cells (Fig. 3C).robo2 is expressed in central retina at E13, with especially high levels on the vitreal side, the location of the forming RGC layer (Fig. 3E,D). Expression ofrobo2 spreads peripherally such that at E17 robo2is expressed throughout the retina, again with highest expression in the forming RGC layer (Fig.3F,H).
These data demonstrate that, at the time RGC axons are extending over the diencephalon, robo2, and to a lesser extentrobo1, receptors for Slit1 and Slit2, are expressed in the RGC layer. Given the high, uniform expression of robo2 in the RGC layer, we conclude that most if not all RGCs express it. However, because only a small proportion of cells in the RGC layer highly express robo1, it is difficult to be certain that they are RGCs because a sizeable proportion of cells in the adult RGC layer are displaced amacrine cells (Jeon et al., 1998). In summary, our findings suggest that Slit1 and/or Slit2, acting predominantly through Robo2, may act as diencephalic repellents for RGC axons in vivo.
Expression of Slits in retina
We also examined the expression of slit1,slit2, and slit3 within the retina at E13, E15, and E17. At all ages examined, both slit1 (Fig.4A–C) andslit2 (Fig. 4D–F) are most highly expressed in the RGC layer. Expression is first detected at E13 in central retina but spreads peripherally over time, apparently following the central to peripheral gradient of the generation of RGCs (Morest, 1970). In addition, a domain of high slit2 expression surrounds RGC axons coursing through the optic nerve (Fig.4E,F). In contrast,slit3 (Fig. 4G–I) is not expressed to any significant degree in the retina at any of the ages examined. At E17,slit1 exhibits a graded, high ventral to low dorsal expression pattern. These data suggest that in vivo, Slit1 and Slit2, acting predominantly through Robo2, and to a lesser extent through Robo1, may be involved in intraretinal development. In addition, if both Robo and Slit proteins are present on RGC axons, they might modulate interactions between RGC axons.
Slit2 biases and inhibits retinal axon growth in collagen gels
To determine the effects of Slit2 on RGC axon growth, we cocultured in three-dimensional collagen gels explants of retina at a distance from aggregates of 293T cells transiently transfected withslit2-myc cDNA or with vector cDNA as a control. Similar analyses were not done for Slit1 because we have not been able to produce sufficient levels of Slit1 protein by transfection. Explants of retina were prepared from E15 rat embryos, an age when RGC axons are extending over the diencephalon in vivo and are responsive to the hypothalamic and epithalamic repellent activities in vitro (Tuttle et al., 1998).
Axon outgrowth from retinal explants is robust when cocultured with mock-transfected cells (Fig.5A–D), whereas when cocultured with slit2-transfected cells (Fig.5E–H), outgrowth is substantially decreased. Overall, axon growth appears to be biased away from the cells, and often bundles of axons originate on the explant side facing theslit2-transfected cells (Fig. 5G). We quantified several features of axon outgrowth in the cocultures, including the bias in outgrowth, the length of axon bundles, and the total number of axon bundles, using the scheme presented in Figure6A. When retina is cocultured with mock-transfected cells (n = 18), 35% more axon bundles extend from the side facing toward the cells compared with the side away from them (Fig. 6B). In contrast, when retina is cocultured with slit2-transfected cells (n = 20), 30% fewer axon bundles emanate from the side facing toward the cells (Fig. 6B). Comparison between the two types of cocultures reveals that the ratio of toward to away is decreased by ∼50% in the Slit2 cocultures. Thus, Slit2 substantially alters the distribution of axon outgrowth from retinal explants, resulting in a biased outgrowth away from the source of Slit2. In addition, Slit2 results in a decrease in the length of retinal axon bundles. In cocultures with mock-transfected cells, axon bundles are the same length on the explant sides toward and away from the cells, whereas in the Slit2 cocultures, they are 35% shorter on the side toward the slit2-transfected cells compared with the away side (Fig. 6C). This decrease in the length of axon bundles suggests that Slit2 slows the rate of retinal axon extension.
The overall axon outgrowth from retinal explants is also diminished in the presence of slit2-transfected cells. Counts of the total number of axon bundles emanating from retinal explants in the cocultures shows that the number is decreased by 84% in the cocultures with slit2-transfected cells compared with mock-transfected cells (Fig. 6D). Thus, Slit2 is a potent inhibitor of retinal axon growth in vitro. The growth inhibition of Slit2 appears to be concentration-dependent because, on the explant side facing the slit2-transfected cells in which the amount of Slit2 protein should be greater, fewer axon fascicles emerge (Fig.6B) and they are shorter (Fig. 6C).
Although retinal axon outgrowth is fasciculated in both sets of cocultures, the axon bundles generally appear to be denser, that is more tightly fasciculated, in the presence of Slit2 (Fig. 5). To assess the degree of fasciculation, we digitally measured the optical density of the axon bundles immunostained using an anti-β-tubulin antibody, with the rationale being that more tightly fasciculated axon bundles should exhibit a greater optical density (see Materials and Methods). Retinal explants cocultured with mock-transfected cells had an average pixel value of 100 ± 1.5 (on a scale of 0 to 256), whereas those cocultured with slit2-transfected cells had an average pixel value of 114.7 ± 5.9. This difference was highly significant (p < 0.005; Student's t test). We therefore conclude that retinal axons are more tightly fasciculated in the presence of Slit2.
The findings described above demonstrate that Slit2 inhibits retinal axon growth and alters the distribution of outgrowth from retinal explants, resulting in a biased growth away from the source of Slit2. To determine whether Slit2 also has a directional affect on retinal axon growth, especially whether it repels retinal axons, we measured the angle of deviation of axons away from slit2-transfected cells (Fig. 7A). We found no significant difference in axon turning when retinal explants are cocultured with slit2-transfected compared with mock-transfected cells (Fig. 7B). Thus, although Slit2 biases and inhibits retinal axon growth in vitro, we are lacking formal criteria that Slit2 is also a chemorepellent for retinal axons.
DISCUSSION
Our previous work showed that the hypothalamus and epithalamus release a soluble repellent activity for rat and mouse retinal axons and that the distribution of this activity correlates with the fasciculation and innervation patterns of RGC axons within the embryonic diencephalon (Tuttle et al., 1998). Here, we presented evidence that the axonal chemorepellents Slit1 and Slit2 comprise the diencephalic repellent activity. At the time RGC axons extend over the diencephalon, slit1 and slit2 are expressed in the hypothalamus and epithalamus but not in RGC target nuclei in dorsal thalamus, and most if not all RGCs express the Slit receptorrobo2, and a limited number might express robo1. In addition, our in vitro assays show that Slit2 is a potent inhibitor of retinal axon growth. These findings, together with those of Erskine et al. (2000) and Niclou et al. (2000), suggest that the slits have crucial roles in RGC axon pathfinding from the eye to the midbrain.
Within the retina, we find that the Robo receptors and slit1and slit2 are coexpressed in the RGC layer, withslit1 exhibiting a high ventral to low dorsal graded expression. Other axon guidance ligands and receptors are also coexpressed in the retina, often in a graded manner in the RGC layer, including EphA and EphB receptors and their ephrin-A and ephrin-B ligands (Cheng et al., 1995; Kenny et al., 1995; Marcus et al., 1996; Braisted et al., 1997; Holash et al., 1997; Monschau et al., 1997). The graded expression of the ephrin-A ligands appears to regulate the pool of functional EphA receptors on RGCs via receptor phosphorylation and influence RGC axon guidance by enhancing the gradient of functional receptors (Connor et al., 1998; Hornberger et al., 1999). Although the role of the coincident expression of the Slits and Robos in RGCs is undefined, it may serve to modulate axon–axon interactions within the RGC axon pathway and thereby influence the fasciculation of RGC axons and their responses to Slits expressed along the pathway (see below).
It seems likely that robo2 is the primary mediator of RGC axon response to the Slits, because it is expressed at much higher levels in the RGC layer than robo1. However, the relative contributions of Slit1 and Slit2 in influencing RGC axon growth within the diencephalon is less clear. We have shown that Slit2 inhibits retinal axon growth and is expressed in the hypothalamus and epithalamus at the time RGC axons extend over the diencephalon.slit1 is also highly expressed in the hypothalamus and epithalamus in a pattern that partially overlaps with that ofslit2, but thus far we have not tested its function. However, Slit1 is a repellent for olfactory axons (Yuan et al., 1999) and migrating olfactory progenitor cells (Wu et al., 1999). Therefore, it is likely that both Slit1 and Slit2 are components of the hypothalamic and epithalamic repellent activities.
The expression patterns of slit1 and slit2, and our findings that RGC axon growth is both inhibited and more tightly fasciculated in the presence of slit2, relate well to the fasciculation and innervation patterns of RGC axons within the diencephalon. RGC axons are tightly bundled and invade sparsely if at all parts of the diencephalon that express the slits, i.e., the hypothalamus and epithalamus, and are defasciculated and innervate parts that do not express the slits, i.e., their target nuclei in the lateral part of dorsal thalamus. The fasciculation pattern of the RGC axons in relation to domains of ;slit expression is consistent with the demonstration that retinal axons are able to extend over an inhibitory substratein vitro but in a highly fasciculated manner (Bray et al., 1980). Thus, one possible role for the Slits expressed in the hypothalamus and epithalamus is to promote the fasciculation of RGC axons. The defasciculation of RGC axons over dorsal thalamus may be allowed by its lack of Slit expression and could be enhanced by a Slit-mediated repulsion between RGC axons because RGCs appear to express Robos and Slits. The potential action of the Slits on RGC axon fasciculation may be similar to the influences of the ephrin-A axonal repellents on the fasciculation of cortical axons (Winslow et al., 1995) and retinal axons (McLaughlin and O'Leary, 1999).
Because the hypothalamus expresses slit1 andslit2, it may seem counterintuitive that RGC axons enter the brain at its ventral aspect and extend dorsally over its surface. It is likely though that the Slit-mediated inhibition is balanced by activities that promote and direct RGC axon growth, for example the chemoattractant netrin-1 (De la Torre et al., 1997; Deiner et al., 1997). This idea is supported by analyses of RGC axon pathfinding in mice deficient for the homeodomain protein Vax1 (Bertuzzi et al., 1999). vax1 is expressed in discrete populations of cells of the optic stalk, nerve and chiasm, and ventral hypothalamus. In vax1 mutants, RGC axons fail to form a chiasm and very few penetrate the brain. Instead, at their entry point in ventral hypothalamus, RGC axons form a “Probst-like” bundle that is capped by an aberrant dense cluster of cells, which are normallyvax1+. Thus, a domain that is normally growth permissive for RGC axons, is inhibitory in the mutants: a change that correlates with a dramatic decrease innetrin-1 expression but maintained expression ofslit1 (Bertuzzi et al., 1999). Similarly,netrin-1 expressed at the optic disk and in the optic nerve may neutralize any inhibitory effects on RGC axon growth exerted by Slit2 expressed at the optic disk and bounding the nerve (Fig.3E,F), which may help explain why the optic nerve is reduced or absent in netrin-1mutant mice (Deiner et al., 1997). In normal development, the expression of slit2 surrounding the optic nerve may serve to channel RGC axons from the eye to the brain.
RGCs innervate their targets via branches that form along RGC axons at specific locations within the optic tract (Bhide and Frost, 1991; Simon and O'Leary, 1992a,b). Our findings suggest that the Slits may prevent RGC axons from forming and extending branches into nontarget tissues. This could be achieved in two ways. First, the Slits could directly inhibit branch formation and extension, similar to apparent role of ephrin-A in inhibiting retinal axon branching (Roskies and O'Leary, 1994; O'Leary et al., 1999). This action is the opposite of that of the N-terminal fragment of Slit2, which promotes the elongation and branching of dorsal root ganglia axons in vitro (Wang et al., 1999). A second way would be a result of Slit-mediated modulation of axon fasciculation; the defasciculation of RGC axons over dorsal thalamus should facilitate their branching and innervation of their target nuclei, whereas their branching over the hypothalamus should be diminished by their tight fasciculation. This suggestion is supported by the finding that the branching of corticospinal axons is delayed and diminished by the selective removal of polysialic acid from their surfaces, which results in an increase in their fasciculation (Daston et al., 1996).
As RGC axons approach the domain of slit1 andslit2 expression in the epithalamus, they not only refasciculate but also turn and grow caudally toward the SC, suggesting that the Slits may act in vivo as repellents for RGC axons. Although our in vitro data indicate that Slit2 inhibits retinal axon growth, our analysis of axon turning failed to provide evidence that Slit2 is a chemorepellent for retinal axons. Although we previously referred to the unidentified hypothalamic and epithalamic activities as repellents for retinal axons (Tuttle et al., 1998), we did not perform a quantitative analysis of axon turning as we have done for Slit2. However, we did find that retinal axon growth is biased away from the hypothalamus and epithalamus in vitro, similar to our finding here that retinal axon growth is biased away fromslit2-transfected cells. Although our data do not reveal a directional, i.e., repellent, effect of Slit2 on retinal axons, the Slits might nonetheless act in vivo as repellents and promote RGC axon turning. We suspect that axon turning in the collagen cocultures is impeded by the fasciculation of rat retinal axons, which is enhanced in the presence of Slit2. This situation has similarities to the effect of chemoattractant netrin-1 on spinal commissural axons: although netrin-1 can cause the turning of spinal axons under some conditions in vitro (Kennedy et al., 1994; Hong et al., 1999), in collagen gels it induces the outgrowth of axon bundles but does not affect their directionality (Kennedy et al., 1994).
We conclude that Slit1 and Slit2 play a role in the pathfinding of RGC axons and the patterning of their projections within the diencephalon by regulating the fasciculation of RGC axons within the optic tract, preventing them or their branches from invading nontarget tissues and steering them toward their distal target, the SC. It will be of interest to determine the requirement of the Slits for the development of RGC projections and to identify other molecules that cooperate with the Slits to define the path of RGC axons through the diencephalon and promote their innervation of their dorsal thalamic targets.
Footnotes
This work was supported by National Institutes of Health Grant EY07025 (D.D.M.O'L.). C.G. and M.T.L. are Investigators of the Howard Hughes Medical Institute. T.R. is supported by the Swedish Brain Foundation and the Swedish Medical Research Council.
Drs. Ringstedt and Braisted contributed equally to this work
Correspondence should be addressed to Dennis D. M. O'Leary, Molecular Neurobiology Laboratory, The Salk Institute, 10010 North Torrey Pines Road, La Jolla, CA 92037. E-mail: doleary{at}salk.edu.